Trial Profile
Use of Intracameral Moxifloxacin for the Prevention of Acute Endophthalmitis Following Cataract Surgery: a Controlled and Randomized Clinical Trial
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 28 Aug 2018
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Endophthalmitis
- Focus Therapeutic Use
- 15 May 2018 Status changed from recruiting to discontinued.
- 24 Oct 2017 Planned End Date changed from 1 May 2018 to 1 May 2019.
- 24 Oct 2017 Planned primary completion date changed from 1 May 2017 to 1 May 2018.